Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Sep;11(3):409-419.
doi: 10.1007/s12178-018-9503-2.

Low-Virulence Organisms and Periprosthetic Joint Infection-Biofilm Considerations of These Organisms

K Keely Boyle  1 , Stuart Wood  2 , T David Tarity  3
Affiliations
Review

Low-Virulence Organisms and Periprosthetic Joint Infection-Biofilm Considerations of These Organisms

K Keely Boyle et al. Curr Rev Musculoskelet Med. 2018 Sep.

Abstract

Purpose of review: The purpose of this manuscript is to provide a critical review of peer-reviewed literature over the last 5 years related to low virulent organisms associated with periprosthetic joint infection (PJI). We evaluated the most common organisms, the diagnostic challenges, and the novel tools available in the perioperative workup of PJI as well as the current understanding of how biofilm potentiates the indolent clinical presentation and explore a possible shift in the surgical management of these patients.

Recent findings: Biofilm actively prevents macrophage phagocytosis by suppressing proinflammatory activity through the recruitment of myeloid-derived suppressor cells. Given the appropriate host and organism conditions, increased utilization of one-stage exchange arthroplasty in the surgical treatment of these low virulent infections may be on the rise. Biomarkers and molecular techniques offer encouraging results to diagnose low virulent organisms and future research focused on the disruption of biofilm may ultimately give rise to improved treatment strategies.

Keywords: Biofilm; Low-virulent organisms; Periprosthetic infection.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest

The authors declare that they have no conflicts of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Figures

Fig. 1
Fig. 1
P. acnes strains 77 and 87 on Brucella Blood Agar plates demonstrating the hemolytic phenotype as defined by greater than 2 mm of clearance surrounding the bacteria
Fig. 2
Fig. 2
P acnes strains 83 and 84 on Brucella Blood Agar plates not demonstrating the hemolytic phenotype as shown by no evidence of clearance around the bacteria
Fig. 3
Fig. 3
P. acnes strain 64 on the left demonstrating resistance to clindamycin by showing the bacteria growing up to the e test strip at the highest minimum inhibitory concentration (MIC). P. acnes strain 64 on the right showing an MIC of 0.25 for cephalothin (first-generation cephalosporin), which is considered susceptible based on EUCAST (European Committee on Antimicrobial Susceptibility Testing) standards
Fig. 4
Fig. 4
S. epidermidis biofilm formation when evaluating microfluidic devices for studying growth and detachment of S. epidermidis biofilms. Reprinted with permission from Lee, JH., Kaplan, J.B., and Lee, W.Y. Biomed Microdevices (2008) 10: 489. 10.1007/s10544-007-9157-0. Please note that this photo originally appeared in a multi-paneled figure. The “(b)” on the image is not relevant to this review
Fig. 5
Fig. 5
a, b MRSA (clinical isolate NRS70) biofilm image by scanning electron microscope (SEM) grown on titanium in vitro. Courtesy of Caelen Clark, PhD University at Buffalo
See this image and copyright information in PMC

References

    1. Bozic KJ, Kurtz SM, Lau E, Ong K, Chiu V, Vail TP, Rubash HE, Berry DJ. The epidemiology of revision total knee arthroplasty in the United States. Clin Orthop Relat Res. 2010;468(1):45–51. doi: 10.1007/s11999-009-0945-0. - DOI - PMC - PubMed
    1. Delanois RE, Mistry JB, Gwam CU, Mohamed NS, Choksi US, Mont MA. Current epidemiology of revision Total knee arthroplasty in the United States. J Arthroplast. 2017;32(9):2663–2668. doi: 10.1016/j.arth.2017.03.066. - DOI - PubMed
    1. Gwam CU, Mistry JB, Mohamed NS, Thomas M, Bigart KC, Mont MA, Delanois RE. Current epidemiology of revision total hip arthroplasty in the United States: National Inpatient Sample 2009 to 2013. J Arthroplast. 2017;32(7):2088–2092. doi: 10.1016/j.arth.2017.02.046. - DOI - PubMed
    1. Singh JA, Sperling JW, Schleck C, Harmsen WS, Cofield RH. Periprosthetic infections after total shoulder arthroplasty: a 33-year perspective. J Shoulder Elb Surg. 2012;21(11):1534–1541. doi: 10.1016/j.jse.2012.01.006. - DOI - PMC - PubMed
    1. Patton D, Kiewiet N, Brage M. Infected total ankle arthroplasty: risk factors and treatment options. Foot Ankle Int. 2015;36(6):626–634. doi: 10.1177/1071100714568869. - DOI - PubMed

LinkOut - more resources